Losartan Potassium and Ezetimibe prescription drug bottles
Publicado el 29 de agosto de 2019
Resumen
CPSC registra el retiro 19194, publicado el 29 de agosto de 2019. Unidades reportadas: About 636,000.
Qué peligro representa
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Qué hacer
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
Recibe un correo cuando CPSC publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Distribuidor
- Sandoz Inc., of Princeton, N.J.
- País
- US
Retiros relacionados
- CPSCUltra-Soft Turkish robes30 de agosto de 2019
- CPSCChildren's chairs and stools30 de agosto de 2019
- CPSCFolding patio chairs29 de agosto de 2019
- CPSCUbbi Connecting Bath Toys29 de agosto de 2019
- CPSCRocky Screwgate carabiners29 de agosto de 2019
- CPSCYamaha golf cars, personal transportation and specialty vehicles28 de agosto de 2019
Preguntas sobre este retiro
¿Losartan Potassium and Ezetimibe prescription drug bottles fue retirado del mercado?
Sí. CPSC publicó el retiro 19194 el 29 de agosto de 2019. Peligro reportado: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
¿Qué debo hacer si tengo este producto?
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.